Daisuke Hazama

848 total citations
31 papers, 608 citations indexed

About

Daisuke Hazama is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Daisuke Hazama has authored 31 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 7 papers in Immunology. Recurrent topics in Daisuke Hazama's work include Lung Cancer Treatments and Mutations (6 papers), Phagocytosis and Immune Regulation (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Daisuke Hazama is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Phagocytosis and Immune Regulation (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Daisuke Hazama collaborates with scholars based in Japan, Sweden and Switzerland. Daisuke Hazama's co-authors include Tatsuya Nagano, Yoshihiro Nishimura, Kazuyuki Kobayashi, Tatsunori Kiriu, Masatsugu Yamamoto, Masahiro Katsurada, Motoko Tachihara, Naoko Katsurada, Takenori Kotani and Reina Sekiya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Daisuke Hazama

29 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Hazama Japan 12 219 212 208 143 75 31 608
Xin Lei China 13 137 0.6× 114 0.5× 60 0.3× 109 0.8× 50 0.7× 30 439
Marie Müller France 12 84 0.4× 148 0.7× 173 0.8× 265 1.9× 61 0.8× 30 546
Corey Carter United States 11 71 0.3× 161 0.8× 144 0.7× 147 1.0× 21 0.3× 24 417
Mingen Liu United States 8 380 1.7× 271 1.3× 59 0.3× 189 1.3× 25 0.3× 14 678
Mayur D. Mody United States 8 58 0.3× 208 1.0× 162 0.8× 214 1.5× 34 0.5× 13 628
Jadzia Tin-Tsen Chou Poland 6 97 0.4× 150 0.7× 70 0.3× 157 1.1× 15 0.2× 15 421
R. J. Seager United States 7 81 0.4× 162 0.8× 65 0.3× 96 0.7× 28 0.4× 17 342
Benoît Vallée France 14 65 0.3× 70 0.3× 155 0.7× 236 1.7× 31 0.4× 19 486
Yuzhen Yin China 13 119 0.5× 190 0.9× 125 0.6× 182 1.3× 17 0.2× 34 520
Jiongke Wang China 11 120 0.5× 100 0.5× 93 0.4× 303 2.1× 18 0.2× 39 582

Countries citing papers authored by Daisuke Hazama

Since Specialization
Citations

This map shows the geographic impact of Daisuke Hazama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Hazama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Hazama more than expected).

Fields of papers citing papers by Daisuke Hazama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Hazama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Hazama. The network helps show where Daisuke Hazama may publish in the future.

Co-authorship network of co-authors of Daisuke Hazama

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Hazama. A scholar is included among the top collaborators of Daisuke Hazama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Hazama. Daisuke Hazama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagano, Tatsuya, Daisuke Hazama, Naoko Katsurada, et al.. (2025). Reduction in circulating Endothelin-1 levels by inhaled COPD medications. Respiratory Medicine. 240. 108027–108027.
2.
Nagano, Tatsuya, Daisuke Hazama, Daisuke Tamura, et al.. (2024). Mechanism of action of adapalene for treating EGFR‐TKI‐induced skin disorder. Thoracic Cancer. 15(9). 722–729. 2 indexed citations
3.
Nagano, Tatsuya, Reina Sekiya, Takehiro Otoshi, et al.. (2024). Effects of Tongue Strength Training on Patients with Mild to Moderate Sleep-disordered Breathing: A Randomized Controlled Trial. Progress in Rehabilitation Medicine. 9(0). n/a–n/a. 3 indexed citations
4.
Fukui, Takafumi, Daisuke Hazama, Naoko Katsurada, et al.. (2024). Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma. Thoracic Cancer. 15(15). 1228–1236. 4 indexed citations
5.
Katsurada, Naoko, et al.. (2024). Successful Treatment with Ramucirumab Plus Erlotinib following Osimertinib-induced Interstitial Lung Disease. Internal Medicine. 64(5). 749–751. 1 indexed citations
6.
Fukui, Takafumi, Hiroki Sato, Koichi Furukawa, et al.. (2024). Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing. BMC Cancer. 24(1). 489–489. 1 indexed citations
7.
Saito, Yasuyuki, Alaa Refaat, Daisuke Hazama, et al.. (2023). Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models. Frontiers in Immunology. 14. 1294814–1294814. 4 indexed citations
8.
Katsurada, Naoko, Takafumi Fukui, Jun Yamada, et al.. (2023). Diagnostic yield and the number of tumor cells of ultrathin bronchoscopy for peripheral lung lesions: A comparison with thin bronchoscopy. PLoS ONE. 18(8). e0290609–e0290609. 3 indexed citations
9.
Enomoto, Yasunori, Hiroaki Katsura, Takashi Fujimura, et al.. (2023). Autocrine TGF-β-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nature Communications. 14(1). 4956–4956. 55 indexed citations
10.
Hazama, Daisuke, Motoko Tachihara, Hiroki Sato, et al.. (2022). The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study. Thoracic Cancer. 13(21). 3052–3057. 9 indexed citations
11.
Katsurada, Masahiro, Motoko Tachihara, Naoko Katsurada, et al.. (2022). Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy. BMC Cancer. 22(1). 539–539. 4 indexed citations
12.
Otoshi, Takehiro, Tatsuya Nagano, Shintaro Izumi, et al.. (2021). A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensor. Scientific Reports. 11(1). 9973–9973. 20 indexed citations
13.
Nagano, Tatsuya, Shintaro Izumi, Teruaki Nishiuma, et al.. (2021). Characteristics of the nocturnal desaturation waveform pattern of SpO2 in COPD patients: an observational study. Respiratory Research. 22(1). 276–276. 8 indexed citations
14.
Katsurada, Naoko, Motoko Tachihara, Tatsunori Kiriu, et al.. (2020). <p>Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC</p>. Cancer Management and Research. Volume 12. 777–782. 4 indexed citations
15.
Hazama, Daisuke, Yizhen Yin, Yoji Murata, et al.. (2020). Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy. Cell chemical biology. 27(9). 1181–1191.e7. 46 indexed citations
16.
Kiriu, Tatsunori, Masatsugu Yamamoto, Tatsuya Nagano, et al.. (2019). <p>Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study</p>. OncoTargets and Therapy. Volume 12. 10559–10568. 18 indexed citations
17.
Katsurada, Masahiro, Tatsuya Nagano, Motoko Tachihara, et al.. (2019). Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer. Anticancer Research. 39(2). 815–825. 74 indexed citations
18.
Nagano, Tatsuya, Takehiro Otoshi, Daisuke Hazama, et al.. (2019). <p>Novel cancer therapy targeting microbiome</p>. OncoTargets and Therapy. Volume 12. 3619–3624. 26 indexed citations
19.
Kiriu, Tatsunori, Masatsugu Yamamoto, Tatsuya Nagano, et al.. (2018). The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer. PLoS ONE. 13(2). e0193018–e0193018. 60 indexed citations
20.
Murata, Yoji, Sei‐ichiro Motegi, Eri Arai, et al.. (2017). Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2(1). e89140–e89140. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Lei Breakdown of academic impact, for papers by Marie Müller Breakdown of academic impact, for papers by Corey Carter Breakdown of academic impact, for papers by Mingen Liu Breakdown of academic impact, for papers by Mayur D. Mody Breakdown of academic impact, for papers by Jadzia Tin-Tsen Chou Breakdown of academic impact, for papers by R. J. Seager Breakdown of academic impact, for papers by Benoît Vallée Breakdown of academic impact, for papers by Yuzhen Yin Breakdown of academic impact, for papers by Jiongke Wang
Rankless by CCL
2026